Fever
Fever
References
- Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old — Pediatrics, American Academy of Pediatrics (Pantell RH, Roberts KB, Adams WG, et al.). Pediatrics 2021;148(2):e2021052228
- Fever and Antipyretic Use in Children — Pediatrics, American Academy of Pediatrics — Section on Clinical Pharmacology and Therapeutics and Committee on Drugs (Sullivan JE, Farrar HC). Pediatrics 2011;127(3):580-587
- Fever in under 5s: assessment and initial management — National Institute for Health and Care Excellence. NICE guideline NG143
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America — Clinical Infectious Diseases, Infectious Diseases Society of America (Freifeld AG, Bow EJ, Sepkowitz KA, et al.). Clin Infect Dis 2011;52(4):e56-e93
- Prophylactic drug management for febrile seizures in children — Cochrane Database of Systematic Reviews (Offringa M, Newton R, Nevitt SJ, et al.). Cochrane Database Syst Rev 2021;6(6):CD003031
- Drug Fever: A Critical Appraisal of Conventional Concepts — Annals of Internal Medicine (Mackowiak PA, LeMaistre CF). Ann Intern Med 1987;106(5):728-733
- A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial Infections — JAMA Pediatrics (Kuppermann N, Dayan PS, Levine DA, et al.; PECARN). JAMA Pediatr 2019;173(4):342-351
- Prospective Evaluation of the Risk of Serious Bacterial Infection in Children Who Present to the Emergency Department With Hyperpyrexia — Pediatrics, American Academy of Pediatrics (Trautner BW, Caviness AC, Gerlacher GR, et al.). Pediatrics 2006;118(1):34-40
- Approach to the Febrile Infant (under 3 Months) — Pediatric Emergency Care (Grief MM, Yamamoto LG). Pediatr Emerg Care 2023;39(11):875-879
- Maternal Heat Exposure and Neural Tube Defects — JAMA (Milunsky A, Ulcickas M, Rothman KJ, et al.). JAMA 1992;268(7):882-885
- Short-term Dual Therapy or Monotherapy With Acetaminophen and Ibuprofen for Fever: A Network Meta-Analysis — Pediatrics, American Academy of Pediatrics (De la Cruz-Mena JE, Veroniki AA, Acosta-Reyes J, et al.). Pediatrics 2024;154(4):e2023065390
- Antipyretic Strategies: Is Fever Clearance Enough to Justify Dual Therapy? — Pediatrics, American Academy of Pediatrics (Wade KC, Mathis C). Pediatrics 2024;154(4):e2024067408
- Aspirin and Reye Syndrome — Pediatrics, American Academy of Pediatrics, Committee on Infectious Diseases. Pediatrics 1982;69(6):810-812
- Physical methods for treating fever in children — Cochrane Database of Systematic Reviews (Meremikwu M, Oyo-Ita A). Cochrane Database Syst Rev 2003;(2):CD004264
- ACOG Response to Consensus Statement on Paracetamol Use During Pregnancy — American College of Obstetricians and Gynecologists. ACOG Statement, September 29, 2021
- Unit of Measurement Used and Parent Medication Dosing Errors — Pediatrics, American Academy of Pediatrics (Yin HS, Dreyer BP, Ugboaja DC, et al.). Pediatrics 2014;134(2):e354-e361
Clinical Snapshot
Fever is a regulated, protective physiologic response in which the hypothalamus raises the body's thermoregulatory set point, most often in response to infection — it reflects the body's beneficial host defence working as intended, not a disease in itself.[1] A commonly used definition is a rectal or rectal-equivalent temperature consistently over 38°C (100.4°F), with slightly lower thresholds recognizing normal diurnal variation of about 0.5°C — over 37.2°C in the early morning or over 37.8°C later in the day.[2] The febrile response rarely exceeds 41-42°C, and fever itself is not inherently harmful in most patients. Because fever is a symptom and not a diagnosis, the clinical task is always to identify and manage the underlying cause, while treating the fever itself only for comfort — a distinction that runs through every part of this chapter, especially the pediatric-specific content below.
Recognize the Condition
General presentation
Fever can be accompanied by malaise, fatigue, headache, backache, myalgia, arthralgia, drowsiness, and chills or rigors. These accompanying symptoms track with the degree of temperature elevation or with the underlying illness itself, and their presence or absence does not reliably indicate how serious the underlying cause is.
Atypical presentation by age
Infants younger than 3 months and older adults (65 years and older) may not mount a measurable fever even in the presence of serious infection — they can instead remain normothermic or become hypothermic. A normal or low temperature in these 2 groups does not rule out serious illness and should not be reassuring on its own if the rest of the clinical picture suggests infection.[1]
Confirming fever: measurement method and route
Every measurement route only approximates core temperature, so the same route should be used for serial comparisons in one patient rather than switching routes and comparing readings directly. Axillary and infrared tympanic measurement are reasonable screening methods through childhood; oral measurement is used once a patient is old enough to cooperate reliably and in adults; rectal measurement gives the most precise reading in young infants and is used specifically when that precision changes management, such as deciding whether a neonate meets the threshold for an emergency sepsis workup.[3]
| Measurement route | Typical normal range | Practical notes |
|---|---|---|
| Axilla | 36.5-37.5°C | Reasonable screening method at any age; least invasive; confirm with another route if a borderline result changes management. |
| Tympanic (infrared ear) | 35.8-37.9°C | Fast and well tolerated; technique-dependent (cerumen, probe angle); less reliable as a screening tool in young infants. |
| Oral | 35.5-37.5°C | Needs a cooperative patient; avoid within 10 minutes of a hot or cold drink or smoking. |
| Rectal | 36.6-37.9°C | Most accurate peripheral method in young infants; avoid with neutropenia, recent anorectal surgery, or rectal anomalies. |
| Temporal artery (forehead) | Device-specific | Quick and non-contact; less accurate than rectal in children — do not rely on it alone to exclude fever when clinical suspicion is high. |
Risk Factors
- Age under 3 months — the single most important risk factor for occult serious bacterial infection presenting as fever.
- Immunocompromised state, including neutropenia, active chemotherapy, chronic high-dose corticosteroid use, HIV infection, primary immunodeficiency, and functional or anatomic asplenia (including sickle cell disease).
- Incomplete or unknown immunization status.
- Indwelling hardware — central venous catheter, ventriculoperitoneal shunt, urinary catheter, prosthetic joint, or prosthetic heart valve.
- Chronic underlying illness — congenital heart disease, chronic lung disease, chronic renal disease, or a metabolic/genetic disease.
- Recent antimicrobial use, which can partially treat and mask an evolving infection.
- Recent travel to a malaria-endemic or other infectious-disease-endemic region, or a known sick contact.
- A new medication started in the preceding weeks — a prompt to consider drug-induced fever (see Assessment and Diagnosis).
Red Flags & Refer
Any of the following warrants urgent medical evaluation rather than reassurance and antipyretic advice alone:
- Fever in a neonate younger than 28 days old — this requires an urgent full sepsis workup (blood culture, urinalysis and urine culture, cerebrospinal fluid studies) and empiric parenteral antibiotics regardless of how well the infant looks; a neonate's fever is never "just a cold."[1]
- Fever with a petechial or purpuric rash.
- Signs of meningismus — neck stiffness, a bulging fontanelle in an infant, photophobia, or a headache disproportionate to the rest of the illness.
- Fever in an immunocompromised or neutropenic patient — a true medical emergency regardless of how well the patient otherwise appears, needing immediate referral rather than outpatient antipyretic management (see Special Populations).[4]
- Toxic or lethargic appearance — poor perfusion, inconsolability, a weak or high-pitched cry, marked irritability, or reduced responsiveness — regardless of the actual temperature reading; a low-grade fever in a toxic-appearing patient is more concerning than a high fever in a well-appearing one.
- Fever with signs of significant dehydration, respiratory distress, or hemodynamic instability.
- A seizure with fever that is prolonged (over 15 minutes), focal, recurs within 24 hours, or occurs in a child younger than 6 months or older than 6 years — these features define an atypical or complex febrile seizure rather than a typical simple febrile seizure and need evaluation.[5]
- Fever persisting more than 24 hours with no apparent source in a child, fever persisting more than 3 days in anyone regardless of cause, or recurrent fever.
- Very high fever (over 40.5°C).
Assessment & Diagnosis
Fever vs. hyperthermia — a critical distinction
These 2 states are commonly conflated but are physiologically different and need different treatment; antipyretic drugs work by lowering the hypothalamic set point, so they are pharmacologically useless for true hyperthermia.
| Feature | Fever | Hyperthermia |
|---|---|---|
| Mechanism | Hypothalamic set point is raised — a regulated, controlled process | Set point is normal; heat production or environmental heat gain exceeds the body's ability to dissipate it — an unregulated failure of thermoregulation |
| Typical causes | Infection, malignancy, rheumatologic or immunologic disease, drug-induced fever | Heat stroke/environmental heat exposure, malignant hyperthermia, neuroleptic malignant syndrome, serotonin syndrome, thyroid storm, anticholinergic toxicity |
| Response to antipyretics | Effective — lowers the set point the body is actively defending | Ineffective — there is no elevated set point to lower |
| Temperature ceiling | Rarely exceeds 41-42°C | Can rise to dangerous levels with no inherent physiologic ceiling |
| Primary treatment | Antipyretic drug therapy, plus treatment of the underlying cause | Emergency physical cooling (evaporative and conductive methods) plus a specific antidote when one exists (e.g., dantrolene for malignant hyperthermia) — drug antipyretics are not the treatment |
History
- Onset, duration, and pattern of the fever, plus associated localizing symptoms (respiratory, urinary, gastrointestinal, skin, neurologic).
- Immunization status, recent travel, sick contacts, and daycare or school attendance.
- Underlying chronic illness, immunosuppression, or recent surgery/instrumentation.
- Every current medication and supplement, prescription and nonprescription — drug-induced fever is uncommon but genuinely underrecognized; reported causes include allopurinol, amphotericin B, antihistamines, antipsychotics, atropine and other anticholinergics, azathioprine, barbiturates, carbamazepine, corticosteroids, cyclosporine, digoxin, diltiazem, doxepin, epinephrine, folic acid, furosemide, heparin, hydralazine, hydrochlorothiazide, H2-receptor antagonists, insulin, interferon, iodides, iron dextran, isoniazid, MAOIs, methyldopa, metoclopramide, mycophenolate, nifedipine, NSAIDs, oral contraceptives, penicillins/cephalosporins/sulfamethoxazole-trimethoprim and other antibacterials, phenytoin, procainamide, propylthiouracil, quinidine, quinine, rifampin, salicylates, sulfasalazine, tacrolimus, triamterene, and vitamins. Suspect drug-induced fever when fever appears after a new drug is started, no other source is found despite a reasonable workup, and the fever resolves after the drug is stopped.[6]
Physical examination
A complete examination looking for a focal source, with particular attention to overall appearance (toxic versus well), work of breathing, perfusion, hydration status, rash, and neck stiffness. The degree of illness on examination — not the absolute temperature — should drive the urgency of workup and referral.
When investigations are — and are not — indicated
Aggressiveness of laboratory and imaging workup depends on age, clinical severity, symptoms pointing to a specific focus (urinary, respiratory), and comorbidity or immune status. A well-appearing child older than 3 months with a clear benign source (e.g., a typical viral upper respiratory illness) and reassuring follow-up generally needs no bloodwork or imaging. Nonspecific inflammatory markers — procalcitonin, C-reactive protein, or white blood cell count with or without differential — are not sensitive or specific enough on their own to replace clinical assessment of severity, though procalcitonin has a defined, validated role inside specific low-risk infant prediction rules (see below).[7] Bacteremia is more likely when the temperature exceeds 41.1°C, a reasonable trigger to lower the threshold for blood cultures in that specific situation.[8]
Age-stratified risk approach to the febrile infant and child
Neonates: birth to 28 days old
Highest risk. Any temperature at least 38°C is itself a red flag regardless of how well the infant appears — proceed to full evaluation (blood culture, urinalysis and urine culture, cerebrospinal fluid studies), empiric parenteral antibiotics, and admission. Within this band, infants 8-21 days old are managed with the most uniformly aggressive approach; infants 22-28 days old still require full evaluation, though some validated algorithms incorporate inflammatory markers into the decision to perform a lumbar puncture.[1]
Young infants: 29-60 days old
Still substantial risk, but a well-appearing infant in this band who meets validated low-risk criteria (normal urinalysis, a reassuring absolute neutrophil count, and procalcitonin below the validated cutoff) may be managed with a more selective approach — deferring lumbar puncture and antibiotics in favour of close observation and confirmed follow-up — through shared decision-making between the clinician and caregiver. This remains a same-day, clinician-level decision, not a "watch and see at home" recommendation from a community pharmacy counter.[7]
Older infants: 61-90 days old
Progressively lower risk with increasing age. A well-appearing infant in this band with no identifiable focal bacterial source and low-risk laboratory criteria can often be managed without lumbar puncture or empiric antibiotics, with close follow-up.[9]
Children 3 months to 36 months old
Lower risk again once the child is fully immunized and well-appearing with no focal source — most fever in this age group is viral and self-limited. Routine bloodwork and imaging are not needed for a well-appearing, reassuring presentation; reassess if fever persists more than 24 hours with no apparent cause or more than 3 days regardless of cause.
Children older than 36 months, and adults
Standard history- and examination-driven evaluation directed at finding a focal source. Clinical severity — not the number on the thermometer — should guide the urgency of workup and referral, and a response to antipyretic therapy does not exclude serious underlying illness.
Older adults (65 years and older)
A separate high-risk group at the other end of the age spectrum: a blunted febrile response means a normal or only mildly elevated temperature can still reflect serious infection — maintain a lower threshold of concern in this group than the absolute temperature alone would suggest.
Treatment Targets
- Relieve discomfort and distress caused by the fever itself — the goal is comfort, not achieving a "normal" temperature reading.
- Identify and appropriately manage (treat, or safely observe) the underlying cause of the fever.
- Balance the benefit of symptomatic treatment against the cost, adverse effects, and dosing-error risk of antipyretic medication.
- Relieve caregiver or parental anxiety about fever ("fever phobia") through accurate counselling, without over-treating a well-appearing patient.
- In a pregnant patient, particularly during the first trimester, reduce the risk of adverse fetal outcomes associated with maternal heat exposure.[10]
Choose Initial Treatment
Whether to treat at all
Treat fever with an antipyretic only when the patient is uncomfortable, distressed, or otherwise unwell because of the fever — not simply because the number on the thermometer has crossed a threshold. A well-appearing patient who is playing, feeding, or sleeping normally does not need antipyretic treatment, and does not need to be woken up to receive a scheduled dose.[2]
First-line antipyretic selection
1st line acetaminophen (any age, weight-based dosing) or 1st line ibuprofen (age at least 6 months, weight-based dosing) — both are equally acceptable first-choice antipyretics for comfort. Choose between them based on age eligibility, the dosing device or formulation on hand, and any contraindication (avoid ibuprofen if the patient is dehydrated or has renal impairment).
Combining or alternating acetaminophen and ibuprofen
Alternative — use only when a single agent alone is not achieving comfort a short course of alternating or combined dosing can be considered under pharmacist- or prescriber-directed guidance with an explicit written schedule. Current evidence shows this approach can produce more time without fever than either drug used alone, but it has not been shown to improve the patient's actual comfort beyond a single agent, and it meaningfully increases the risk of dosing confusion and inadvertent overdose from running 2 concurrent regimens.[11][12] It is never the routine default first step, and it is never used simply to chase a lower number on the thermometer.
Salicylate and NSAID age restrictions
Do not use ASA (acetylsalicylic acid) for fever in anyone younger than 18-19 years of age because of the risk of Reye syndrome[13]; naproxen is not recommended for fever in children younger than 12 years of age.
Pregnancy
In a pregnant patient — particularly during the first trimester — treat fever proactively with acetaminophen, since maternal heat exposure itself has been associated with an increased risk of neural tube defects and other congenital anomalies.[10] Avoid ASA and NSAIDs in pregnancy, especially in the first and third trimesters (see Special Populations).
Non-Pharmacologic Treatment
- Dress the patient in light, breathable clothing and keep ambient room temperature around 20-21°C — avoid both overbundling, which traps heat, and excessive undressing.
- Encourage increased fluid intake to replace insensible losses from fever and reduce the risk of dehydration.
- Avoid strenuous physical exertion while febrile.
- Tepid sponging is not recommended as a routine measure. It does lower temperature transiently, but the effect is short-lived, and the shivering and vasoconstriction the body mounts to defend its still-elevated set point make it uncomfortable without added benefit once an antipyretic is on board; if physical cooling is used at all, give the antipyretic first, since sponging before the set point is lowered simply drives the body to generate more heat to fight the cooling.[14]
- Never use alcohol sponging — isopropyl or rubbing alcohol can be absorbed through the skin or inhaled, and has caused hypoglycemia, intoxication, and coma.
- Reserve physical cooling methods (tepid sponging, cooling blankets, fanning) for the rare situation of a core temperature over 41-42°C, and only after the patient has been appropriately investigated — physical methods are for very high fever in a monitored setting, not routine outpatient management.
Pharmacologic Treatment Options
| Drug / intervention | Role | Dose / use | Important adverse effects | Teaching points |
|---|---|---|---|---|
| Acetaminophen Preferred | 1st-line antipyretic, any age | 10-15 mg/kg PO/PR every 4-6 hours PRN; maximum 5 doses or 75 mg/kg in 24 hours, whichever is lower, not exceeding the adult maximum | Uncommon at recommended doses; hepatotoxicity with overdose or chronic excess | Dose by weight, not age. Confirm the exact product concentration every time — infant drops and children's suspensions are not the same strength. |
| Ibuprofen Preferred | 1st-line antipyretic, age at least 6 months | 5-10 mg/kg PO every 6-8 hours PRN; maximum 40 mg/kg/day, not exceeding the adult maximum | GI upset; rare renal effects, especially with dehydration | Avoid if the patient is dehydrated. Give with food if GI upset occurs. |
| Naproxen sodium Alternative | Longer-acting NSAID option, adults and children age at least 12 years | 220 mg PO every 8-12 hours PRN; maximum 440 mg/day (self-care) | GI upset, fluid retention | Not recommended under age 12. Less frequent dosing than ibuprofen is the main practical advantage. |
| ASA (acetylsalicylic acid) Special situation | Adult-only antipyretic option | 325-650 mg PO every 4-6 hours PRN; maximum 4000 mg/day | GI upset/bleeding; tinnitus at high dose | Avoid entirely in anyone younger than 18-19 years because of Reye syndrome risk. Not a routine first antipyretic choice even in adults, given equally effective and better-tolerated alternatives. |
Special Populations
Pregnancy
Treat fever in pregnancy, particularly during the first trimester — maternal heat exposure itself has been associated with an increased risk of neural tube defects and other congenital anomalies, independent of the underlying cause of the fever.[10] Acetaminophen is the preferred antipyretic throughout pregnancy, used at the lowest effective dose for the shortest duration needed — a clearly indicated fever is exactly the kind of appropriate, time-limited use major obstetric bodies continue to describe when identifying acetaminophen as one of the few consistently safe analgesic/antipyretic options in pregnancy.[15] Avoid ASA and NSAIDs — they can interfere with labour, cause premature closure of the ductus arteriosus, and increase bleeding risk around delivery; avoidance is strictest in the first and third trimesters.
Breastfeeding
Acetaminophen, ibuprofen, and naproxen are all considered compatible with breastfeeding at standard doses. ASA should be used with caution, if at all, given case reports of infant platelet dysfunction and the availability of safer alternatives.
Pediatrics — the highest-stakes population for dosing accuracy
Always dose acetaminophen and ibuprofen by the patient's actual weight in kilograms, never by age alone. Confirm the exact product concentration being used every time — infant drops and children's suspensions of the same drug are not interchangeable volume-for-volume, and this exact mismatch is a well-documented cause of real overdoses.[16] See Assessment and Diagnosis for the age-stratified risk approach to the febrile infant, and Common Errors to Avoid for the specific dosing-error patterns to counsel against.
Immunocompromised and neutropenic patients
Fever in a neutropenic patient — defined as an absolute neutrophil count under 500 cells/mm³, or under 1000 cells/mm³ with an expected decline, together with a single temperature at least 38.3°C or a temperature at least 38.0°C sustained over 1 hour — is a true medical emergency requiring immediate referral for empiric broad-spectrum antibiotics. It is never managed with an antipyretic and reassurance in the community pharmacy setting.[4]
Older adults
A blunted febrile response means serious infection can present with a normal or only mildly elevated temperature — maintain a lower threshold of concern for this age group than the absolute temperature would otherwise suggest (see Assessment and Diagnosis).
Renal and hepatic impairment
Avoid ibuprofen, and NSAIDs generally, in significant renal impairment or when the patient is dehydrated — prostaglandin inhibition can worsen renal perfusion. Use acetaminophen with caution, and consider a reduced maximum daily dose, in significant hepatic impairment or active liver disease.
Monitoring & Follow-Up
Take a temperature only if the patient feels warm or looks unwell, to establish a baseline — routine repeat measurement more than 2-4 times daily is not needed and tends to feed unnecessary anxiety rather than change management, a pattern sometimes described as "fever phobia."[2] The trajectory of illness and how the patient looks, not the exact temperature trend, should guide ongoing concern. Seek medical attention if fever persists more than 24 hours with no apparent source, persists more than 3 days regardless of cause, or recurs after resolving.
- Monitor every patient started on an antipyretic for rash or signs of an allergic reaction.
- Monitor for signs of dehydration; if using an NSAID, stop it if dehydration develops.
- Monitor for common adverse effects — GI upset with NSAIDs — and watch for signs of hepatotoxicity with high-dose or prolonged acetaminophen use.
- At every fever-related encounter, confirm the correct product, concentration, and measuring device are being used, and that the patient is not exceeding the maximum recommended daily dose — including contributions from other coadministered acetaminophen- or ibuprofen-containing products such as combination cough-and-cold preparations.
- Confirm the patient is not on an interacting medication (see Drug Tables) and counsel to avoid alcohol while taking NSAIDs or acetaminophen.
Treatment Failure / Next Step
- Reassess for red flags before assuming this is simple treatment failure — a response, or lack of response, to an antipyretic does not confirm or exclude a serious underlying cause.
- Confirm the correct weight-based dose, product concentration, and measuring device are actually being used — a dosing error is a far more common explanation for "the medication isn't working" than true treatment failure.
- Confirm the maximum daily dose has not already been reached, including contributions from other coadministered products.
- If a single agent genuinely is not achieving comfort at a correct, maximized dose and interval, consider a pharmacist- or prescriber-directed short course of alternating or combined acetaminophen and ibuprofen with an explicit written schedule, rather than leaving the caregiver to improvise the timing.[11]
- If fever persists beyond the expected duration for the presumed cause (more than 24 hours with no apparent source, or more than 3 days regardless of cause), or recurs, refer for medical reassessment rather than continuing to escalate antipyretic therapy at home.
Common Errors to Avoid
- Treating fever to "break" it or normalize the number on the thermometer, rather than treating for comfort.
- Dosing by age instead of the patient's actual weight — the single most common and most consequential dosing error.
- Confusing infant drops with children's suspension concentrations of the same drug, or switching between formulations without recalculating the volume.
- Using a kitchen spoon instead of the calibrated device supplied with the product.
- Not asking about other coadministered acetaminophen- or ibuprofen-containing products (combination cough/cold/analgesic products), risking an inadvertent cumulative overdose.
- Using ASA for fever in a child or adolescent younger than 18-19 years — Reye syndrome risk.
- Using naproxen for fever in a child younger than 12 years.
- Waking a sleeping patient specifically to give a scheduled antipyretic dose — not necessary.
- Alternating or combining acetaminophen and ibuprofen as a routine default rather than a deliberate, explicitly scheduled exception — the leading cause of dosing confusion between the 2 agents.
- Giving prophylactic antipyretics before or immediately after routine immunization — this has not been shown to meaningfully reduce fever and may blunt the vaccine antibody response; reserve antipyretic use for a genuinely uncomfortable patient after vaccination.[2]
- Recommending antipyretics to prevent febrile seizures — a persistent myth. Antipyretic therapy does not prevent febrile seizures, and prophylactic antipyretic or anticonvulsant use is not recommended for this purpose.[5]
- Using alcohol sponging to cool a febrile patient.
- Assuming a fever that responds to antipyretic therapy cannot be a serious infection — response to treatment does not rule out serious illness.
- Missing a drug-induced cause of fever in a patient recently started on a new medication with no other identifiable source.
Clinical Decision Algorithm
Drug Tables
How to use this table: Doses are self-care doses and require patient-specific confirmation, including weight-based recalculation and renal/hepatic adjustment. Select any drug name to open its complete Pharmasist Drug Database page.
Para-aminophenol derivatives
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Acetaminophen | Children (weight-based): 10-15 mg/kg PO/PR every 4-6 hours PRN; maximum 5 doses or 75 mg/kg in 24 hours, whichever is lower, not exceeding the adult maximum Adults: 325-650 mg PO/PR every 4-6 hours PRN; maximum 4000 mg/day (some product labels now recommend a lower 3000 mg/day self-care ceiling — check the specific product) | Uncommon at recommended doses; hepatotoxicity with overdose, chronic excess, or in patients with liver disease; rare hypersensitivity | Increased hepatotoxicity risk with chronic alcohol use and enzyme inducers (e.g., carbamazepine, phenytoin, rifampin); sustained higher-dose use can increase INR in patients on warfarin — monitor if used regularly alongside warfarin | Available as oral drops, syrup/suspension, chewable tablets, tablets, and suppositories — concentrations vary by formulation, so always confirm the specific product's concentration before calculating a dose. Not a treatment for hyperthermia (see Assessment and Diagnosis). |
NSAIDs
Avoid in dehydration or significant renal impairment; give with food if GI upset occurs.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Ibuprofen | Children under 6 months: Not established for routine use — use only under specific medical direction Children 6 months and older: 5-10 mg/kg PO every 6-8 hours PRN; maximum 40 mg/kg/day, not exceeding the adult maximum Adults (self-care): 200-400 mg PO every 4-6 hours PRN; maximum 1200 mg/day self-care, up to 2400 mg/day if supervised by a prescriber | GI upset and bleeding/ulceration with prolonged use, allergic reactions, tinnitus, rare nephropathy, sodium and water retention | Increased GI bleeding risk with alcohol, corticosteroids, anticoagulants, SSRIs; can blunt the antihypertensive effect of ACE inhibitors, beta-blockers, and diuretics; increases cyclosporine and lithium levels; can reduce the antiplatelet effect of ASA when taken concurrently | Not established for routine use under 6 months of age — data are limited; use only under specific direction. Many combination cold/flu products also contain ibuprofen — check labels to avoid double-dosing. |
| Naproxen sodium | Children under 12 years: Not recommended Adults and children age at least 12 years: 220 mg PO every 8-12 hours PRN; maximum 440 mg/day (self-care) | GI upset and bleeding/ulceration with prolonged use, allergic reactions, tinnitus, rare nephropathy, sodium and water retention | Same NSAID-class interaction profile as ibuprofen — alcohol, corticosteroids, anticoagulants, SSRIs, ACE inhibitors/beta-blockers/diuretics, cyclosporine, lithium | Longer half-life allows less frequent dosing than ibuprofen; the main practical reason to choose it over ibuprofen in an eligible patient. |
Salicylates
Reserve for adults; not a routine first antipyretic choice even in adults given equally effective, better-tolerated alternatives.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| ASA (acetylsalicylic acid) | Children and adolescents under 18-19 years: Not recommended — Reye syndrome risk Adults: 325-650 mg PO every 4-6 hours PRN; maximum 4000 mg/day | GI upset and bleeding/ulceration, allergic reactions including ASA-sensitive asthma, tinnitus at high dose | Increased GI bleeding risk with alcohol, corticosteroids, other NSAIDs, anticoagulants, SSRIs; can blunt the antihypertensive effect of ACE inhibitors, beta-blockers, and diuretics; increases cyclosporine and lithium levels; reduces the uricosuric effect of probenecid/sulfinpyrazone | Avoid entirely under 18-19 years of age for fever because of Reye syndrome risk. Enteric-coated products have a delayed onset of action — not ideal when a fast antipyretic effect is needed. |
Fixed-dose combination products
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Acetaminophen / ibuprofen (fixed-dose combination) | Adults: Per product labelling — confirm the acetaminophen and ibuprofen content of each dose against the maximum daily dose of each component separately | Combined adverse-effect profile of both components — see each drug above | See each component above | A fixed ratio does not allow independent titration of each component. Reserve for an adult with an established need for combined therapy rather than using it as a convenient substitute for a properly scheduled, pharmacist- or prescriber-directed alternating regimen. |
Evidence note: Drug inventory, dosing, adverse effects, and comments reflect standard Canadian self-care and prescribing practice, cross-checked against the current AAP clinical report on antipyretic use and current product labelling.[2]
Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.